Skip to main content

SHLP2 vs Dihexa

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

SHLP2

SHLP2 (Small Humanin-Like Peptide 2) is a mitochondrial-derived peptide similar to humanin. It has shown insulin-sensitizing and cytoprotective effects in research, with potential metabolic benefits.

Full details →

Dihexa

Dihexa is a nootropic peptide derived from angiotensin IV. It has shown remarkable cognitive-enhancing properties in animal studies, being described as potentially millions of times more potent than BDNF.

Full details →

Side-by-Side Comparison

AspectSHLP2Dihexa
MechanismEnhances insulin sensitivity and glucose uptake. Provides cytoprotective effects similar to humanin. May act through similar but distinct receptor pathways.Acts as a hepatocyte growth factor (HGF) potentiator by binding to its receptor c-Met. Promotes synaptogenesis, neuronal survival, and cognitive enhancement through this pathway.
Typical DosageResearch compound with doses in the microgram to low milligram range studied in animal models. Human dosing not established.Research dosing is highly variable due to extreme potency. Typical range: 10-40mg orally or sublingually. Start with lowest doses due to potency.
AdministrationSubcutaneous or intraperitoneal injection in research settings. Various SHLP analogs (1-6) have different properties.Can be taken orally, sublingually, or intranasally. Extremely potent - careful dosing is essential. Best used cyclically.
Side EffectsLimited data. Animal studies suggest good tolerability. May affect glucose metabolism.Limited human data. Reported effects include headache, temporary brain fog during adjustment, and potential mood changes.
Best For

Key Differences

Detailed Analysis

Dihexa and SHLP2 are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose Dihexa for Cognitive Performance. Choose SHLP2 for Fat Loss, Anti-Aging & Longevity.

Ready to Learn More?